期刊文献+
共找到738篇文章
< 1 2 37 >
每页显示 20 50 100
Antineoplastic Effect of Calcium Channel Blocker-Verapamil and 5-Fluorouracil Intraperitoneal Chemotherapy on Hepatocarcinoma-Bearing Rats
1
作者 曹天生 史海安 周亚魁 《The Chinese-German Journal of Clinical Oncology》 CAS 2002年第2期84-87,共4页
Objective To study the antineoplastic effect of the calcium channel blocker verapamil and 5-fluorouracil intraperitoneal chemotherapy on hepatocarcinoma-bearing rats,and examine the action between calcium channel bloc... Objective To study the antineoplastic effect of the calcium channel blocker verapamil and 5-fluorouracil intraperitoneal chemotherapy on hepatocarcinoma-bearing rats,and examine the action between calcium channel blockers and cytotoxic drugs. Methods We adopted the method of subcapsular implantation of carcinoma tissues of walker-256 in the left liver lobe as a model of liver carcinoma-bearing rats.All experimental animals were divided into four groups.On the sixth day post implantation,in group A (control group) 6ml of saline was injected intraperitoneally once a day for 3 days.In group B(single chemotherapy group) 6ml of 5-Fu 75 mg/kg was injected intraperitoneally once a day for 3 days.In group C(combination of treatment group)both 5-Fu(75mg/kg) and verapamil (25mg/kg) were administered simultaneously as in A and B.In group D(simple verapamil group)only 6ml of verapamil(25mg/kg)was administered as above. Results Compared with groups A, B and D,The volume of cancer and the contents of liver cancer DNA and protein were significantly reduced.The rates of inhibiting cancer(89.9% in group C and 35.4% in group B)were significantly increased in groupC. Group C had significantly long survival time compared to groups A, B and D(P<0.05).By light microscopy, a number of focal necroses were found in cancer tissue in group C.Conclusion Calcium channel blockers can enhance the antineoplastic effect of 5-Fu intraperitonea chemotherapy to liver cancer;The use of verapamil can not increase the toxicity of 5-Fu. 展开更多
关键词 钙通道阻滞剂 5-氟尿嘧啶 维拉帕米 肝细胞癌 荷瘤大鼠 腹腔内化疗 抗肿瘤作用
下载PDF
Calcium channel blockers and Alzheimer's disease 被引量:2
2
作者 Yi Tan Yulin Deng Hong Qing 《Neural Regeneration Research》 SCIE CAS CSCD 2012年第2期137-140,共4页
Alzheimer's disease is characterized by two pathological hallmarks: amyloid plaques and neurofibrillary tangles. In addition, calcium homeostasis is disrupted in the course of human aging Recent research shows that ... Alzheimer's disease is characterized by two pathological hallmarks: amyloid plaques and neurofibrillary tangles. In addition, calcium homeostasis is disrupted in the course of human aging Recent research shows that dense plaques can cause functional alteration of calcium signals in mice with Alzheimer's disease. Calcium channel blockers are effective therapeutics for treating Alzheimer's disease. This review provides an overview of the current research of calcium channel blockers involved in Alzheimer's disease theraov. 展开更多
关键词 Alzheimer's disease caic-ium channel calcium homeostasis Alzheimer's diseasepathogenesis Β-AMYLOID calcium channel blocker
下载PDF
Calcium channel blocker monotherapy versus combination with reninangiotensin system inhibitors on the development of new-onset diabetes mellitus in hypertensive Korean patients 被引量:3
3
作者 Yong Hoon Kim Ae-Young Her +16 位作者 Seung-Woon Rha Byoung Geol Choi Se Yeon Choi Jae Kyeong Byun Yoonjee Park Dong Oh Kang Won Young Jang Woohyeun Kim Woong Gil Choi Tae Soo Kang Jihun Ahn Sang-Ho Park Ji Young Park Min-Ho Lee Cheol Ung Choi Chang Gyu Park Hong Seog Seo 《Journal of Geriatric Cardiology》 SCIE CAS CSCD 2019年第6期439-447,共9页
Background In real practice, two or more antihypertensive drugs are needed to achieve target blood pressure. We investigated the comparative beneficial actions of combination therapy of renin-angiotensin system inhibi... Background In real practice, two or more antihypertensive drugs are needed to achieve target blood pressure. We investigated the comparative beneficial actions of combination therapy of renin-angiotensin system inhibitors (RASI), with calcium channel blockers (CCB) over CCB monotherapy on the development of new-onset diabetes mellitus (NODM) in Korean patients during four-year follow-up periods. Methods A total of 3208 consecutive hypertensive patients without a history of diabetes mellitus who had been prescribed CCB were retrospectively enrolled from January 2004 to December 2012. These patients were divided into the two groups according to the additional use of RASI (the RASI group, n = 1221 and the no RASI group, n = 1987). Primary endpoint was NODM, defined as a fasting blood glucose ≥ 126 mg/dL or hemoglobin A1c ≥ 6.5%. Secondary endpoint was major adverse cardiac events (MACE) defined as total death, myocardial infarction (MI) and percutaneous coronary intervention (PCI). Results After propensity score-matched (PSM) analysis, two propensity- matched groups (939 pairs, n = 1878, C-statistic = 0.743) were generated. The incidences of NODM (HR = 1.009, 95% CI: 0.700–1.452, P = 0.962), MACE (HR = 0.877, 95% CI: 0.544–1.413, P = 0.589), total death, MI, PCI were similar between the two groups after PSM during four years. Conclusions The use of RASI in addition to CCB showed comparable incidences of NODM and MACE compared to CCB monotherapy in non-diabetic hypertensive Korean patients during four-year follow-up period. However, large-scaled randomized controlled clinical trials will be required for a more definitive conclusion. 展开更多
关键词 calcium channel blocker Diabetes mellitus RENIN-ANGIOTENSIN system INHIBITORS
下载PDF
Effect of Calcium Ionophore and Calcium Channel Blockers on Immediate Hypersensitivity Reactions
4
作者 黄钦田 陈丙莺 孙爱民 《The Journal of Biomedical Research》 CAS 1994年第1期26-28,共3页
The release of mediators from mast cells is a model for cell secretion and is an in-vitro index for immediate hypersensitivity reactions. Calcium influx is generally accepted to be the primary biochemicalevent in mast... The release of mediators from mast cells is a model for cell secretion and is an in-vitro index for immediate hypersensitivity reactions. Calcium influx is generally accepted to be the primary biochemicalevent in mast cell activation.We studied the effect of the calcium ionophore A 23187 and calcium channelblockers,nifedipine and verapamil, in triggering the activation of rat peritoneal mast cells.At suitableconcentration nifedipine and verapamil have had the inhibition effect in the IgE-dependent roaction. 展开更多
关键词 calcium ionophore A23187 calcium channel blocker NIFEDIPINE VERAPAMIL mediator Histamine
下载PDF
Calcium Channel Blockers《钙离子阻断剂》
5
作者 苏定冯 《中国药理学通报》 CAS CSCD 北大核心 2005年第2期140-140,共1页
关键词 阻断剂 钙通道 对抗药 慢通道 凝血因子Ⅳ 钙离子 calcium Channel blockers
下载PDF
钙通道阻滞剂1,4-二氢吡啶类药物的绿色合成
6
作者 谢建武 刘俊男 谢玄升 《陕西科技大学学报》 北大核心 2024年第1期65-72,共8页
心脏及心脑血管疾病是发达国家人群的第一死因,也是中国人死亡的首位原因.L-型钙通道是目前临床上主要使用选择性钙通道阻滞剂1,4-二氢吡啶类药物.文章研究了在非均相催化剂离子交换树脂Amberlyst 15的催化以及无溶剂条件下,高效的合成... 心脏及心脑血管疾病是发达国家人群的第一死因,也是中国人死亡的首位原因.L-型钙通道是目前临床上主要使用选择性钙通道阻滞剂1,4-二氢吡啶类药物.文章研究了在非均相催化剂离子交换树脂Amberlyst 15的催化以及无溶剂条件下,高效的合成了钙通道阻滞剂1,4-二氢吡啶类药物.该反应体系具有原料便宜、反应时间短、操作及后处理简单、催化剂可回收利用、反应可放大等优良特点. 展开更多
关键词 药物合成 钙通道阻滞剂 1 4-二氢吡啶 绿色合成 非均相催化
下载PDF
钙通道阻滞剂对未破裂颅内动脉瘤影响的研究进展
7
作者 万子豪 李爱民 《中国医药》 2024年第7期1091-1095,共5页
未破裂的颅内动脉瘤是一颗埋在患者体内的定时炸弹,这类患者往往伴有高血压病。除去多数研究已证实的促破裂危险因素以外,复杂的血流动力学、炎症因素以及未控制的高血压也增加了其破裂风险。作为临床常用的抗高血压药物,钙通道阻滞剂... 未破裂的颅内动脉瘤是一颗埋在患者体内的定时炸弹,这类患者往往伴有高血压病。除去多数研究已证实的促破裂危险因素以外,复杂的血流动力学、炎症因素以及未控制的高血压也增加了其破裂风险。作为临床常用的抗高血压药物,钙通道阻滞剂被发现在促破裂进程中可以发挥保护作用,但也有研究发现了不同甚至矛盾的结果。本文就动脉瘤破裂的危险因素、钙通道阻滞剂使用对瘤体破裂的影响以及发挥的双重效应作一综述。 展开更多
关键词 未破裂颅内动脉瘤 钙通道阻滞剂 血流动力学 慢性炎症 高血压
下载PDF
钙离子通道阻滞剂在慢性疼痛患者中临床应用的研究进展
8
作者 王翼华 王前 +1 位作者 张立贇 梁元 《系统医学》 2024年第4期191-194,共4页
现代医学将疼痛列为继呼吸、脉搏、血压、体温后的第五生命体征,足见其在人体健康中的重要性。慢性疼痛是指超过正常愈合时间(一般指3个月)持续存在的自觉疼痛感,相对于急性疼痛而言,慢性疼痛一般会涉及生理或神经系统,并可能会影响身... 现代医学将疼痛列为继呼吸、脉搏、血压、体温后的第五生命体征,足见其在人体健康中的重要性。慢性疼痛是指超过正常愈合时间(一般指3个月)持续存在的自觉疼痛感,相对于急性疼痛而言,慢性疼痛一般会涉及生理或神经系统,并可能会影响身体的多个方面。由于受到发病机制复杂、个体差异大以及神经可塑性等因素的影响,慢性疼痛的治疗难度相对较大。药物治疗是慢性疼痛管理中的常用手段,关于药物的选择或配伍也一直是临床研究的热点。本文综述了钙离子通道阻滞剂在慢性疼痛中的应用,旨在为疾病的治疗提供参考。 展开更多
关键词 慢性疼痛 钙离子通道阻滞剂 研究进展
下载PDF
Effects of Tetrandrine on Cytosolic Free Calcium in Cultured Bovine Aortic Smooth Muscle Cells 被引量:1
9
作者 李新天 王幼林 《Journal of Chinese Pharmaceutical Sciences》 CAS 1998年第2期38-41,共4页
利用Fura2技术和ARCMMIC阳离子系统研究了粉防己碱对传代培养牛主动脉血管平滑肌细胞内游离钙的影响。粉防己碱(1~100μmol·L-1)不影响血管平滑肌细胞的静息钙,但在有胞外钙存在时,对高钾,5... 利用Fura2技术和ARCMMIC阳离子系统研究了粉防己碱对传代培养牛主动脉血管平滑肌细胞内游离钙的影响。粉防己碱(1~100μmol·L-1)不影响血管平滑肌细胞的静息钙,但在有胞外钙存在时,对高钾,5羟色胺,ATP,血管紧张素I,去甲肾上腺素引起的胞内钙升高有抑制作用;在无胞外钙存在时,粉防己碱对苯肾上腺素引起的胞内钙升高也有一定的抑制作用。粉防己碱对高钾升高内钙的抑制作用呈剂量依赖性,IC50值为9.2(95%可信限:5.7~14.9)μmol·L-1。上述结果提示粉防己碱对血管平滑肌细胞的电压依赖性钙通道和受体调控性钙通道均有阻滞作用,对受体调控性钙通道阻滞作用主要表现为阻滞钙离子内流。 展开更多
关键词 粉防己碱 血管平滑肌细胞 FURA-2 钙通道阻滞剂
全文增补中
Calcium Signaling is Involved in Negative Phototropism of Rice Seminal Roots 被引量:5
10
作者 CHEN Juan MO Yi-wei XU Hua-wei 《Rice science》 SCIE 2014年第1期39-46,共8页
Calcium ions (Ca2+) act as an intracellular second messenger and affect nearly all aspects of cellular life. They are functioned by interacting with polar auxin transport, and the negative phototropism of plant roo... Calcium ions (Ca2+) act as an intracellular second messenger and affect nearly all aspects of cellular life. They are functioned by interacting with polar auxin transport, and the negative phototropism of plant roots is caused by the transport of auxin from the irradiated side to the shaded side of the roots. To clarify the role of calcium signaling in the modulation of rice root negative phototropism, as well as the relationship between polar auxin transport and calcium signaling, calcium signaling reagents were used to treat rice seminal roots which were cultivated in hydroculture and unilaterally illuminated at an intensity of 100-200 pmol/(m2.s) for 24 h. Negative phototropism curvature and growth rate of rice roots were both promoted by exogenous CaCI2 lower than 100 pmol/L, but inhibited by calcium channel blockers (verapamil and LaCI3), calcineurin inhibitor (chlorpromazine, CPZ), and polar auxin transport inhibitor (N-l-naphthylphthalamic acid, NPA). Roots stopped growing and negative phototropism disappeared when the concentrations increased to 100 pmol/L verapamil, 12.500 ~Jmol/L LaCI3, 60 pmol/L CPZ, and 6 pmol/L NPA. Moreover, 100 pmol/L CaCI2 could relieve the inhibition of LaCI3, verapamil and NPA. The enhanced negative phototropism curvature was caused by the transportation of more auxin from the irradiated side to the shaded side in the presence of exogenous Ca2+. Calcium signaling plays a key role as a second messenger in the process of light signal regulation of rice root growth and negative phototropism. 展开更多
关键词 calcium signaling polar auxin transport calcium channel blocker second messenger negative phototropism
下载PDF
The effect of calcium-antagonist on Bcl-2 and Bax mRNA expression following ischemic brain injury 被引量:4
11
作者 周瑞祥 刘昌勤 孙圣刚 《中国临床康复》 CSCD 2003年第4期672-673,共2页
AIM:In order to explore whether the member of Bcl-2 gene family,for example,B cl-2 and Bax,are induced after cerebral ischemia,and whether expression of gene s can be modulated by calcium-antagonist.METHODS:The rat ce... AIM:In order to explore whether the member of Bcl-2 gene family,for example,B cl-2 and Bax,are induced after cerebral ischemia,and whether expression of gene s can be modulated by calcium-antagonist.METHODS:The rat cerebral ischemic mode ls were made by Nagasawa and Zea Longa improvement method,by occluding left midd le cerebral artery;the expression of Bcl-2 and Bax mRNA were measured by RT-PC R method.RESULTS:After administration of nimodipine, Bcl-2 mRNA was up-regulat ed in the hippocampus at 6 and 24 h after ischemia,while Bax mRNA was down-regu lated at 6 and 24h after ischemia.CONCLUSION:Calcium-antagonist can up-regulat e Bcl-2 mRNA and down-regulate Bax mRNA.Increasing the ratio of Bcl-2 and Bax mRNA may contribute to the anti-apoptic effect of nimodipine. 展开更多
关键词 钙拮抗剂 缺血性脑损伤 BCL-2 Bax 基因表达
下载PDF
Argemone mexicana extract alleviates gastrointestinal disorders by stimulating muscarinic receptors and blocking voltage-gated L-type calcium channels
12
作者 Rabia Iqbal Irfan Hamid +7 位作者 Khalid Hussain Janbaz Muhammad Furqan Akhtar Ammara Saleem Ali Sharif Sohaib Peerzada Bushra Akhtar Kashif Sohail Sajid Ali 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2021年第5期214-221,共8页
Objective:To investigate the pharmacological potential of Argemone mexicana in treating constipation and emesis by using in vitro and in vivo models.Methods:The spasmogenic and spasmolytic effects were evaluated on is... Objective:To investigate the pharmacological potential of Argemone mexicana in treating constipation and emesis by using in vitro and in vivo models.Methods:The spasmogenic and spasmolytic effects were evaluated on isolated rabbit jejunum fragments loaded in a tissue organ bath.The response was recorded with an isotonic transducer attached with Power Lab Data Acquisition System.The laxative and antiemetic activities were assessed in BALB-c mice and poultry chicks challenged with carbamylcholine and copper sulphate stimulated emesis,respectively.Results:The total phenolic and total flavonoids contents of the extract were(267.75±5.77)mg GAE/g and(73.86±6.01)mg QE/g,respectively.Argemone mexicana extract exerted spasmogenic effect on isolated rabbit jejunum segments with an EC_(50)value of 0.016 mg/m L,which was blocked by atropine(0.3μM).Argemone mexicana extract exerted spasmolytic effect in atropine treated jejunum fragments with an EC_(50)value of 2.185 mg/mL.Furthermore,Argemone mexicana extract relaxed potassium(80 mM)-induced contractions(EC_(50):9.07 mg/mL),similar to a standard drug verapamil.The calcium channel blocker activity was confirmed by a rightward shift of concentration-response curve of calcium in the presence of Argemone mexicana extract(1-5 mg/mL)and verapamil(0.1-1μM).In addition,the extract increased the distance travelled by a charcoal in the gastrointestinal tract and exhibited antiemetic effect on copper sulphate induced emesis in chicks.Conclusions:Argemone mexicana shows cholinergic agonist and calcium channel blocker activities,as well as antiemetic effect.It may be used as a potential agent for treating gastrointestinal disorders. 展开更多
关键词 Argemone mexicana Muscarinic agonist calcium channel blocker CONSTIPATION EMESIS
下载PDF
Exploiting MCF-7 Cells’ Calcium Dependence with Interlaced Therapy
13
作者 Jonathan Pottle Chengrong Sun +1 位作者 Lloyd Gray Ming Li 《Journal of Cancer Therapy》 2013年第7期32-40,共9页
The purpose of this study is to demonstrate MCF-7 cells’ dependence on calcium for growth and to exploit that dependence to improve chemotherapy efficacy. Fura-2 fluorescence imaging shows that MCF-7 cells maintain a... The purpose of this study is to demonstrate MCF-7 cells’ dependence on calcium for growth and to exploit that dependence to improve chemotherapy efficacy. Fura-2 fluorescence imaging shows that MCF-7 cells maintain a higher basal intracellular calcium concentration than non-tumorigenic MCF-10A cells. Blocking T-type calcium channels with mibefradil reduced MCF-7 intracellular calcium concentration. Flow cytometry shows that knocking down T-type calcium channel expression with siRNA caused an increase in MCF-7 cells in G1 phase and a decrease in cells in S phase. Proliferation assays of MCF-7 cells treated with EGTA and thapsigargin reveal the dependence of MCF-7 cell growth on extracellular and intracellular calcium sources, respectively. In vitro, interlaced treatment that alternated the T-type calcium channel blocker NNC-55-0396 with paclitaxel more effectively reduced MCF-7 cell number than chemotherapy alone. In a mouse in vivo model, interlaced mibefradil and paclitaxel more effectively reduced MCF-7 xenograft size than chemotherapy alone. These findings indicate that MCF-7 cells are dependent on calcium for proliferation, particularly in passing the G1/S cell cycle checkpoint. Further, this dependence on calcium can be exploited by alternating treatment with T-type calcium channel blockers with paclitaxel in an interlaced therapy scheme that increases the efficacy of the chemotherapy. 展开更多
关键词 BREAST Cancer calcium calcium Channel blockerS Ion CHANNELS Interlaced THERAPY
下载PDF
急性钙通道阻滞剂中毒的临床特征研究 被引量:1
14
作者 李辉 任珍 郭治国 《中国全科医学》 CAS 北大核心 2023年第14期1758-1765,共8页
背景 钙通道阻滞剂(CCBs)是我国最常用的一类降压药物,严重CCBs中毒死亡率高,但目前关于其临床特征的相关报道少。目的 通过总结11例急性CCBs中毒患者的临床表现及诊疗结果,分析急性CCBs中毒的临床特点以及血液净化治疗的价值。方法 回... 背景 钙通道阻滞剂(CCBs)是我国最常用的一类降压药物,严重CCBs中毒死亡率高,但目前关于其临床特征的相关报道少。目的 通过总结11例急性CCBs中毒患者的临床表现及诊疗结果,分析急性CCBs中毒的临床特点以及血液净化治疗的价值。方法 回顾性分析2019年1月至2022年6月因CCBs急性中毒就诊于北京大学第三医院急诊科的11例患者的临床表现、症状评分、治疗经过及预后。结果 11例CCBs急性中毒患者中女3例,男8例;平均年龄(39.8±18.0)岁;服药至就诊的中位间隔时间为2.25(6.58)h;来诊时主要临床表现为休克9例(9/11),恶心、呕吐5例(5/11),头晕4例(4/11),乏力3例(3/11),心率增快3例(3/11),心率减慢2例(2/11),晕厥1例(1/11),昏睡1例(1/11)。10例(10/11)患者到达急诊时意识清楚[格拉斯哥昏迷量表(GCS)评分15分]。除了常规治疗,其中6例患者接受血液净化治疗,包括血液灌流联合血浆置换和连续性静脉-静脉血液滤过(CVVH)2例、血液灌流联合CVVH 2例、单独血液灌流2例。此6例中4例患者接受体外膜肺氧合(ECMO)治疗。接受首次血液净化治疗后复查CCBs血药浓度均有下降,硝苯地平下降比例(40.00%~63.64%)高于氨氯地平和维拉帕米(9.09%~26.67%)。11例患者出院时存活9例(9/11)。入院24 h中位急性生理及慢性健康状况评分Ⅱ(APACHEⅡ)评分为10(25)分。入院时中位中毒严重度评分(PSS)为3(1)分。入院时PSS评分为3分的8例患者中死亡2例(2/8),入院时APACHEⅡ评分≥15分的5例患者中死亡2例(2/5)。结论 休克早期意识清晰是急性CCBs中毒较常见表现。在降低血药浓度方面,血液灌流在急性硝苯地平中毒中的作用可能优于在急性氨氯地平和维拉帕米中毒中的作用。APACHEⅡ评分在预测CCBs急性中毒的死亡预后方面可能优于PSS评分。 展开更多
关键词 钙通道阻滞药 中毒 血药浓度 血液净化 临床评分 休克 体外膜肺氧合
下载PDF
多棘蜈蚣钙通道毒素多肽CaTX-Ssmd1原核表达及功能鉴定
15
作者 尹世金 肖敏 +3 位作者 向琪琳 李昱烨 刘柯驿 赵倩茹 《中南民族大学学报(自然科学版)》 CAS 北大核心 2023年第3期313-318,共6页
为了检测广西多棘蜈蚣毒腺转录组文库新基因CaTX-Ssmd1编码的多肽是否具有阻断钙离子通道蛋白的生物活性,将构建的pGEX-4T-1-CaTX-Ssmd1原核表达载体转化Escherichia coli Rosetta(DE3),诱导表达产物经酶切和RP-HPLC分离后得到CaTX-Ssmd... 为了检测广西多棘蜈蚣毒腺转录组文库新基因CaTX-Ssmd1编码的多肽是否具有阻断钙离子通道蛋白的生物活性,将构建的pGEX-4T-1-CaTX-Ssmd1原核表达载体转化Escherichia coli Rosetta(DE3),诱导表达产物经酶切和RP-HPLC分离后得到CaTX-Ssmd1成熟多肽.质谱检测显示CaTX-Ssmd1多肽分子量与理论值一致;钙成像实验表明CaTX-Ssmd1多肽能有效减弱高钾外液灌流激发的小鼠背根神经节(dorsal root ganglion,DRG)细胞[Ca^(2+)]i信号.结论:初步验证了原核表达纯化的CaTX-Ssmd1多肽为新发现的电压门控性钙通道(voltage gated calcium channels,VGCC)阻断剂,丰富了多棘蜈蚣生物活性多肽资源库. 展开更多
关键词 多棘蜈蚣 多肽CaTX-Ssmd1 原核表达 钙通道阻断剂
下载PDF
Advances in Medical Treatment of Primary Aldosteronism 被引量:1
16
作者 Ying-Jie Li Zhi-Gang Ji Jin Wen 《Chinese Medical Sciences Journal》 CAS CSCD 2023年第1期49-56,共8页
Primary aldosteronism(PA)is the most common form of secondary hypertension,with its main manifestations including hypertension and hypokalemia.Early identification of PA is extremely important as PA patients can easil... Primary aldosteronism(PA)is the most common form of secondary hypertension,with its main manifestations including hypertension and hypokalemia.Early identification of PA is extremely important as PA patients can easily develop cardiovascular complications such as atrial fibrillation,stroke,and myocardial infarction.The past decade has witnessed the rapid advances in the genetics of PA,which has shed new light on PA treatment.While surgery is the first choice for unilateral diseases,bilateral lesions can be treated with mineralocorticoid receptor antagonists(MRAs).The next-generation non-steroidal MRAs are under investigations.New medications including calcium channel blockers,macrophage antibiotics,and aldosterone synthase inhibitors have provided a new perspective for the medical treatment of PA. 展开更多
关键词 primary aldosteronism mineralocorticoid receptor antagonists calcium channel blockers macrolide antibiotics aldosterone synthase inhibitors
下载PDF
钙调磷酸酶抑制剂致肾损伤的研究进展
17
作者 孙烜 张坤英 《中国医药导报》 CAS 2023年第24期48-51,共4页
钙调磷酸酶抑制剂(CNI)是一类应用广泛的免疫抑制剂,临床常用的有环孢素A和他克莫司。CNI通过抑制T细胞的活化、诱导T细胞凋亡及抑制多种免疫因子的表达等方式发挥免疫抑制作用,对系统性红斑狼疮、膜性肾病等自身免疫疾病有着显著的治... 钙调磷酸酶抑制剂(CNI)是一类应用广泛的免疫抑制剂,临床常用的有环孢素A和他克莫司。CNI通过抑制T细胞的活化、诱导T细胞凋亡及抑制多种免疫因子的表达等方式发挥免疫抑制作用,对系统性红斑狼疮、膜性肾病等自身免疫疾病有着显著的治疗效果。同时,CNI也存在致肾损伤的毒副作用。CNI可通过激活肾素-血管紧张素-醛固酮系统、破坏肾脏局部血管活性物质的平衡、促进氧化应激等多种方式对肾小球、肾小血管和肾小管及肾间质产生不同程度的损伤。尿视黄醇结合蛋白等生物标志物可能对早期检测CNI所致的肾损伤具有一定价值。钙离子通道拮抗剂则被认为是减轻CNI所致肾损伤的有效手段。本文旨在为应对CNI所致肾损伤提供理论依据和防治思路,促进临床中合理、安全地使用CNI。 展开更多
关键词 钙调磷酸酶抑制剂 肾损伤 钙离子通道拮抗剂 他克莫司
下载PDF
地奥心血康联合钙通道阻滞剂治疗冠心病心绞痛患者疗效的Meta分析
18
作者 李梦媛 曹兆流 鲍柏屹 《中国循证心血管医学杂志》 2023年第7期777-780,792,共5页
目的采用Meta分析方法综合评价地奥心血康联合钙通道阻滞剂治疗心绞痛患者疗效。方法检索2021年12月31日前发表的试验组为地奥心血康联合钙通道阻滞剂治疗心绞痛的随机对照试验(RCT)研究,对照组为单用钙通道阻滞剂,根据纳入和排除标准... 目的采用Meta分析方法综合评价地奥心血康联合钙通道阻滞剂治疗心绞痛患者疗效。方法检索2021年12月31日前发表的试验组为地奥心血康联合钙通道阻滞剂治疗心绞痛的随机对照试验(RCT)研究,对照组为单用钙通道阻滞剂,根据纳入和排除标准筛选文章,并进行数据提取和质量评价,采用RevMan 5.4进行数据分析。结果纳入10篇RCT研究,共计844例患者。地奥心血康联合钙通道阻滞剂在治疗心绞痛总有效率方面高于单用钙通道阻滞剂,有统计学意义(RR=1.25,95%CI:1.17~1.34,P<0.00001);试验组和对照组在发作次数方面两者具有统计学意义(SMD=-7.65,95%CI:-10.17~-5.13,P<0.00001),在持续时间上两者也具有统计学意义的差异(SMD=-9.62,95%CI:-12.76~-6.49,P<0.00001)。结论相较于单用钙通道阻滞剂,联合应用地奥心血康对改善心绞痛的相关结局指标更具优势,但本纳入研究的文献质量普遍较低,期待未来更多高质量RCT支撑本研究结论。 展开更多
关键词 地奥心血康 钙通道阻滞剂 心绞痛 META分析
下载PDF
钙离子拮抗剂联合替格瑞洛治疗高血压合并UAP的效果及其对炎症-微循环状态、MACE发生率的影响
19
作者 宋涛 《检验医学与临床》 CAS 2023年第23期3485-3488,3492,共5页
目的探究钙离子拮抗剂联合替格瑞洛治疗高血压合并不稳定性心绞痛(UAP)的效果及其对炎症-微循环状态、主要心血管不良事件(MACE)发生率的影响。方法选取2021年1月至2022年12月该院收治的120例高血压合并UAP患者作为研究对象,按照抽签法... 目的探究钙离子拮抗剂联合替格瑞洛治疗高血压合并不稳定性心绞痛(UAP)的效果及其对炎症-微循环状态、主要心血管不良事件(MACE)发生率的影响。方法选取2021年1月至2022年12月该院收治的120例高血压合并UAP患者作为研究对象,按照抽签法分为常规组(60例)和试验组(60例)。常规组采用替格瑞洛治疗,试验组采用硝苯地平缓释片联合替格瑞洛治疗。比较两组临床疗效、治疗前后舒张压、收缩压、血脂[血清总胆固醇(TC)、低密度脂蛋白胆固醇(LDL-C)、甘油三酯(TG)]水平、心肌微循环指标(振幅、灌注达峰时间、造影剂开始灌注时间)水平、脑钠肽(BNP)水平、血清炎症因子[超敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子(TNF-α)]水平、MACE发生率及不良反应发生率。结果治疗后试验组临床总有效率(95.00%)高于常规组(83.33%),差异有统计学意义(χ^(2)=4.227,P=0.040)。治疗后两组舒张压、收缩压、TG、TC及LDL-C水平均降低,且试验组均低于常规组,差异有统计学意义(P<0.05)。治疗后两组IL-6、hs-CRP、BNP及TNF-α水平均降低,且试验组均低于常规组,差异有统计学意义(P<0.05)。治疗后试验组MACE发生率(3.33%)低于常规组(13.33%),差异有统计学意义(χ^(2)=3.927,P=0.048)。结论钙离子拮抗剂联合替格瑞洛治疗高血压合并UAP疗效显著,可降低患者血压血脂水平,抑制炎症反应发展,改善心肌微循环,降低MACE发生率。 展开更多
关键词 钙离子拮抗剂 替格瑞洛 高血压 不稳定性心绞痛
下载PDF
不同种类降压药与骨质疏松症相关性研究进展
20
作者 李菊琴 《中国骨质疏松杂志》 CAS CSCD 北大核心 2023年第8期1231-1233,1244,共4页
高血压和骨代谢在生理调节上有共同点,特定种类的降压药也可能影响骨密度或降低骨质疏松症相关骨折风险。虽然现有研究不足以明确哪类降压药对骨骼有益,但目前大部分研究支持血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂和β受体拮抗... 高血压和骨代谢在生理调节上有共同点,特定种类的降压药也可能影响骨密度或降低骨质疏松症相关骨折风险。虽然现有研究不足以明确哪类降压药对骨骼有益,但目前大部分研究支持血管紧张素转换酶抑制剂、血管紧张素受体阻滞剂和β受体拮抗剂能够改善骨密度或降低骨折风险,袢利尿剂则增加骨折风险,而噻嗪类利尿剂和钙通道阻滞剂相关结论互相矛盾。基于高血压的高患病率及降压药的广泛使用,探讨不同种类降压药对骨骼的影响很重要。通过总结近年来关于不同种类降压药与骨质疏松症相关性研究,为易患骨质疏松症高危人群的高血压患者选择合适的降压药提供临床依据。 展开更多
关键词 降压药 利尿剂 钙通道阻滞剂 血管紧张素转换酶抑制剂 血管紧张素受体阻滞剂 Β受体拮抗剂 骨质疏松症
下载PDF
上一页 1 2 37 下一页 到第
使用帮助 返回顶部